Eric Good
Cardiovascular Disease · Ann Arbor, MINPI 1558447698
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.1%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Biotronik Inc. accounts for 84.8% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $23,267 and has fallen 88.7% since, to $2,627 in 2025. Among cardiovascular disease clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $160.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$41K
- Abbott$2K
- Medical Device Business Services, Inc.$2K
- Biosense Webster, Inc.$2K
- Boston Scientific$820
- Medtronic$351
- plus $265 from 7 others
Across 2 payments — averaging $1466.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$3K
What the payments were for
- Consulting fees$3,4507%
- Speaking & faculty fees$6,00012%
- Travel & lodging$24,62851%
- Food & beverage$14,05629%
- Education$880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 250 | $40,869 |
| Abbott | 15 | $2,338 |
| Medical Device Business Services, Inc. | 3 | $1,950 |
| Biosense Webster, Inc. | 4 | $1,630 |
| Boston Scientific | 12 | $820 |
| Medtronic(2 entities) | 6 | $351 |
| Baxter Healthcare | 3 | $106 |
| Johnson & Johnson | 2 | $32 |
| Kestra Medical Technology Services, Inc. | 1 | $31 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $29 |
| Cardiva Medical, Inc. | 1 | $26 |
| Elutia, Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solia$5,575
- BioMonitor$5,439
- Edora$4,406
- Acticor$4,406
- Rivacor$4,185
- Carto 3 System$3,560
- Acticor 7 VR-T DX$2,504
- Edora 8 DR-T$2,359
- Rivacor 7 DR-T$1,860
- Sentus$1,432
- ASSURITY$1,089
- Plexa$934
- AVEIR$892
- Plexa ProMRI$498
- Micra$167
- General - CRM_CRM$114
- EMBLEM$110
- Orsiro Mission$101
- GENERAL TACHY$101
- CoreValve Evolut$100
How this compares
$48,222 in reported general payments places this provider in the 90th percentile of 760 cardiovascular disease providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 17 | $480 |
| Flecainide Acetate | 19 | $408 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 12 | $241 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Ann Arbor
- Marschall RungeAnn Arbor$1.8M
- Vallerie McLaughlinAnn Arbor$947K
- Stanley ChetcutiAnn Arbor$573K
- David BachAnn Arbor$390K
- Bertram PittAnn Arbor$298K
- Victor MolesAnn Arbor$120K
- Salim HayekAnn Arbor$92K
- Ashwini KerkarAnn Arbor$84K
- Priya MehtaAnn Arbor$70K
- Raymond YeowAnn Arbor$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.